Xospata 40 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DR26FCP5W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,946
Award facts
- Contract value 100% obligated
- $18,945.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,945.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XOSPATA 40 mg tablets (90-count units) on November 15, 2025, with an ultimate completion date of December 8, 2025. This non-set-aside competitive award is being fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its prime IDV to supply a diverse range of pharmaceutical products and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's substantial federal contract portfolio demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. This specific delivery order for XOSPATA—a pharmaceutical treatment—exemplifies the type of specialized medical product sourcing that supports military and veteran healthcare operations through DLA's Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26FCP5W?
SPE2DR26FCP5W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 15, 2025.
How much is contract SPE2DR26FCP5W worth?
The government has obligated $18,946 on SPE2DR26FCP5W.
Is contract SPE2DR26FCP5W an order under another contract?
Yes. SPE2DR26FCP5W is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCP5W competed?
The extent of competition for SPE2DR26FCP5W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award